Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 28,000 FHTX shares, $114.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 28,000 | $114.2K |
| Jun 17, 2025 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 25,000 | $119.8K |
| Jun 28, 2024 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | $88.3K |
| Jun 7, 2024 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 54,278 | n/a |
| Jun 23, 2023 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | n/a |
| Jun 9, 2023 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 65,000 | n/a |
| Jun 5, 2023 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 4,216 | n/a |
| Jun 23, 2022 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | n/a |
| Jun 8, 2022 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 65,000 | n/a |
| Jun 6, 2022 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 5,986 | n/a |